Clinical Trial

Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease

Completed
View on ClinicalTrials.gov →
Summary
Local literature is deprived of data comparing the effectiveness of esomeprazole and vonoprazan in patients with gastroesophageal reflux disease (GERD). This study was planned with the objective of comparing the effectiveness of esomeprazole versus vonoprazan in patients diagnosed with GERD.
Trial Details
NCT Number NCT07563491
Lead Sponsor Muhammad Aamir Latif
Conditions Gastro Esophageal Reflux
Enrollment 824 participants
Start Date 2025-01-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-04